Anker SD - Search Results

1

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Flather MD, et al. Among authors: anker sd. Eur Heart J. 2005 Feb;26(3):215-25. doi: 10.1093/eurheartj/ehi115. Epub 2005 Jan 9. Eur Heart J. 2005. PMID: 15642700 Clinical Trial.

2

Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure.

Chua TP, Anker SD, Harrington D, Coats AJ. Chua TP, et al. Among authors: anker sd. Br Heart J. 1995 Oct;74(4):381-5. doi: 10.1136/hrt.74.4.381. Br Heart J. 1995. PMID: 7488451 Free PMC article.

3

Heart rhythms, ventricular arrhythmias, and death in chronic heart failure.

Ponikowski P, Anker SD, Amadi A, Chua TP, Cerquetani E, Ondusova D, O'Sullivan C, Adamopoulos S, Piepoli M, Coats AJ. Ponikowski P, et al. Among authors: anker sd. J Card Fail. 1996 Sep;2(3):177-83. doi: 10.1016/s1071-9164(96)80039-x. J Card Fail. 1996. PMID: 8891855

4

Metabolic, functional, and haemodynamic staging for CHF?

Anker SD, Coats AJ. Anker SD, et al. Lancet. 1996 Dec 7;348(9041):1530-1. doi: 10.1016/S0140-6736(05)66163-6. Lancet. 1996. PMID: 8950874 No abstract available.

5

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction.

Anker SD, Coats AJ. Anker SD, et al. Circulation. 1997 Jan 21;95(2):538-9. Circulation. 1997. PMID: 9008480 No abstract available.

6

The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.

Anker SD, Swan JW, Volterrani M, Chua TP, Clark AL, Poole-Wilson PA, Coats AJ. Anker SD, et al. Eur Heart J. 1997 Feb;18(2):259-69. doi: 10.1093/oxfordjournals.eurheartj.a015229. Eur Heart J. 1997. PMID: 9043843

7

Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex.

Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker SD, Piepoli M, Coats AJ. Chua TP, et al. Among authors: anker sd. Eur Heart J. 1997 Mar;18(3):480-6. doi: 10.1093/oxfordjournals.eurheartj.a015269. Eur Heart J. 1997. PMID: 9076386

8

Wasting as independent risk factor for mortality in chronic heart failure.

Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Anker SD, et al. Lancet. 1997 Apr 12;349(9058):1050-3. doi: 10.1016/S0140-6736(96)07015-8. Lancet. 1997. PMID: 9107242

9

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, Stevenson JC, Coats AJ. Leyva F, et al. Eur Heart J. 1997 May;18(5):858-65. doi: 10.1093/oxfordjournals.eurheartj.a015352. Eur Heart J. 1997. PMID: 9152657

10

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.

Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Anker SD, et al. Am J Cardiol. 1997 May 15;79(10):1426-30. doi: 10.1016/s0002-9149(97)00159-8. Am J Cardiol. 1997. PMID: 9165177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,283 results

Search Page